VF Hive hosts Kristen Scholer and Jon Kelly discuss the week's biggest news stories. From student protests to Jared Kushner's security clearance, it's been a non-stop week in Washington. Vanity Fair's Nick Bilton discusses what the student protest in Tallahassee, Florida could do to change gun-reform. Emma Gonzalez seems to be leading the pack with the #NeverAgain movement. Bilton says a lot of the Gen Z generation has grown up with social media and are comfortable in front of cameras. He notes this may be why it's the first time we're actually seeing a response of this magnitude to a shooting. Plus, Jared Kushner is still fighting for his security clearance. Vanity Fair's Emily Jane Fox says that before the Kushner's even got to the White House they made enemies. However, the biggest enemy of all may be John Kelly. Fox says no one wants the President's daughter and son-in-law running the White House, especially Kelly.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More